The manufacturer Bioteck S.p.A. has published the following safety information due to the detected counterfeiting of its medical device "CHONDROGRID® - INJECTABLE COLLAGEN HYDROLYSATE - 1 BTL 4MG" on the Turkish market New

Safety warnings | Medical devices | 13/06/2024

The manufacturer Bioteck S.p.A. of the CE-marked medical device CHONDROGRID® informs that counterfeits of this product have been found in Turkey.

The counterfeit can be identified by the following characteristics:

  • Transparent glass vial
  • Differences in the labeling of the outer packaging of the counterfeit product

Description of the potential problem:

There is no guarantee for the safety and efficacy of the counterfeit product.

The content of the counterfeit product is not known.

Bioteck S.p.A. is not the manufacturer of the counterfeit product and therefore not responsible for its production and composition.

Measures to be taken by the user:

In the event that a counterfeit product has been obtained, the user is requested to take the following steps:

1) Do not use the product

2) Immediately remove the product to a safe place so that it is available for any (legal) investigations

3) Please send photos of the counterfeit product as well as information about the respective quantity and the supplier from whom the counterfeit product was obtained to the following e-mail address: pms@bioteck.com

The Federal Office for Safety in Health Care (BASG) issues a warning in this regard:

  • It cannot be ruled out that counterfeit products of the type in question are also on the Austrian market.
  • Counterfeit medical devices have no or an unpredictable effect and are to be classified as dangerous. They must not be used under any circumstances.
  • The BASG strongly recommends that medical devices are only purchased via trustworthy distribution channels.
    Medical devices CHONDROGRID® - INJECTABLE COLLAGEN HYDROLYSATE - 1 BTL 4MG

    product number: CHG-004

    GTIN-Code: 8056518500046
    Manufacturer Bioteck S.p.A.
    Safety warnings Link Sicherheitsinformation mit Bildern
    Email

    Further inquiry note